Related Experiment Videos
Safely withdrawing patients from chronic glucocorticoid therapy
1Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
American Family Physician
|February 1, 1997
Summary
Safely withdrawing patients from chronic glucocorticoid therapy requires careful monitoring. An algorithmic approach, patient education, and the cosyntropin challenge are key to preventing adrenal insufficiency during steroid withdrawal.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Chronic glucocorticoid therapy is common but poses risks during withdrawal.
- Adrenal insufficiency symptoms can be subtle, with severe consequences if withdrawal is too rapid.
- Increased use of potent inhaled, intranasal, and topical steroids heightens hypocortisolism risk.
Purpose of the Study:
- To present a safe, practical algorithmic approach for steroid withdrawal.
- To emphasize the importance of reevaluating the need for maintenance steroid therapy.
Main Methods:
- Development of an office-based algorithmic approach for steroid withdrawal.
- Utilizing patient awareness of withdrawal symptoms and close medical follow-up.
- Incorporating the cosyntropin challenge test for assessing adrenal function.
Main Results:
- The proposed algorithm provides a safe and practical method for steroid withdrawal.
- Patient education and proactive symptom reporting are crucial for success.
- The cosyntropin challenge test is a reliable tool in managing steroid withdrawal.
Conclusions:
- A systematic approach to glucocorticoid withdrawal is essential for patient safety.
- Continuous reassessment of steroid necessity and patient monitoring are vital.
- Successful steroid withdrawal relies on physician expertise and patient engagement.